Effects of estrogens and endocrine disruptors on human prostate development and disease

Cowin, Prue Ann (Primary Chief Investigator (PCI))
Risbridger, Gail (Chief Investigator (CI))

Hudson Institute - Department of Molecular and Translational Science

Project: Research

Status	Finished
Effective start/end date	1/01/06 → 31/12/07

Funding

NHMRC - National Health and Medical Research Council (Australia): A$42,462.00
GlaxoSmithKline (GSK) Australia